Related Experiment Video
Updated: Dec 4, 2025
05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
6.4K
Systemic Amyloidosis Due to Clonal Plasma Cell Diseases
1Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Hematology/Oncology Clinics of North America
|October 25, 2020
Summary
Immunoglobulin light chain amyloidosis, a common systemic disease, results from misfolded light chain protein deposits. Early diagnosis and effective therapy are vital to prevent organ damage and mortality.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Immunoglobulin light chain amyloidosis (AL) is the most frequent systemic amyloidosis.
- Pathogenesis involves misfolded immunoglobulin free light chain fibril deposition, predominantly lambda chains from clonal plasma cells.
- Specific Ig light chain variable region genotypes influence tissue tropism in AL amyloidosis.
Purpose of the Study:
- To elucidate the pathogenetic mechanisms of immunoglobulin light chain amyloidosis.
- To highlight the importance of early diagnosis and treatment in managing AL amyloidosis.
- To underscore the role of genetic factors in disease presentation and tissue involvement.
Main Methods:
- Review of pathogenetic mechanisms of AL amyloidosis.
- Analysis of clinical presentation and diagnostic approaches.
- Evaluation of current and emerging therapeutic strategies.
Main Results:
- AL amyloidosis is characterized by the deposition of misfolded immunoglobulin free light chains.
- Genetic variations in Ig light chains determine tissue tropism and disease progression.
- Fibril deposition leads to architectural distortion, cytotoxicity, and rapid organ dysfunction.
Conclusions:
- Prompt diagnosis and initiation of effective combinatorial cytoreductive therapy are critical.
- Intervention is essential to prevent irreversible organ damage and reduce early mortality.
- Understanding genotype-phenotype correlations aids in predicting disease course and guiding treatment.
More Related Videos
Related Concept Videos
03:03Amyloid Fibrils
11.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.4K
03:03Amyloid Fibrils
6.1K
6.1K
01:27Disorders of Leukocytes
1.6K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.6K
01:24Nephrotic Syndrome I : Introduction
304
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
304
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
286
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
286
01:25Cardiomyopathy I: Introduction and Classification
336
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
336